# OnCo record idea-fund-rt-io-platform (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-fund-rt-io-platform/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-fund-rt-io-platform" ;
  schema:name "A neutral platform trial for radiotherapy plus immunotherapy combinations"@en ;
  schema:description "Radiotherapy may make immunotherapy work better, but the trials to test this are scattered and often small. One shared platform, run by radiotherapy groups with drugs supplied by several companies, would settle it faster."@en ;
  schema:url <https://onco.cc/ideas/idea-fund-rt-io-platform/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(15)00223-5> ;
  onco:related <https://onco.cc/pairings/radiation-plus-io/>, <https://onco.cc/ideas/idea-fund-neutral-platform-sponsor/>, <https://onco.cc/ideas/idea-fund-radiotherapy-trials-infrastructure/> ;
  onco:technologies <https://onco.cc/technologies/sbrt/>, <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/imrt-igrt/> ;
  onco:drugs <https://onco.cc/drugs/durvalumab/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/nivolumab/> ;
  onco:terms <https://onco.cc/terms/abscopal-effect/>, <https://onco.cc/terms/oligometastatic/>, <https://onco.cc/terms/basket-umbrella-platform/> ;
  onco:people <https://onco.cc/people/kevin-harrington/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-surgery-radiation-innovation/>, <https://onco.cc/bottlenecks/b-ip-collaboration/>, <https://onco.cc/bottlenecks/b-combination-space/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-sullivan-lancet-oncol/> .
